Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury

Acute lung injury (ALI) is a severe inflammatory lung disease, with high mortality rates. Early intervention by reactive oxygen species (ROS) scavengers could reduce ROS accumulation, break the inflammation expansion chain in alveolar macrophages (AMs), and avoid irreversible damage to alveolar epit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nano letters 2024-05, Vol.24 (20), p.6102-6111
Hauptverfasser: Wang, Haiyan, Jiao, Yunfei, Ma, Shuaijing, Li, Zhuoting, Gong, Jintao, Jiang, Qiao, Shang, Yingxu, Li, Hongling, Li, Jing, Li, Na, Zhao, Robert Chunhua, Ding, Baoquan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6111
container_issue 20
container_start_page 6102
container_title Nano letters
container_volume 24
creator Wang, Haiyan
Jiao, Yunfei
Ma, Shuaijing
Li, Zhuoting
Gong, Jintao
Jiang, Qiao
Shang, Yingxu
Li, Hongling
Li, Jing
Li, Na
Zhao, Robert Chunhua
Ding, Baoquan
description Acute lung injury (ALI) is a severe inflammatory lung disease, with high mortality rates. Early intervention by reactive oxygen species (ROS) scavengers could reduce ROS accumulation, break the inflammation expansion chain in alveolar macrophages (AMs), and avoid irreversible damage to alveolar epithelial and endothelial cells. Here, we reported cell-penetrating R9 peptide-modified triangular DNA origami nanostructures (tDONs-R9) as a novel nebulizable drug that could reach the deep alveolar regions and exhibit an enhanced uptake preference of macrophages. tDONs-R9 suppressed the expression of pro-inflammatory cytokines and drove polarization toward the anti-inflammatory M2 phenotype in macrophages. In the LPS-induced ALI mouse model, treatment with nebulized tDONs-R9 alleviated the overwhelming ROS, pro-inflammatory cytokines, and neutrophil infiltration in the lungs. Our study demonstrates that tDONs-R9 has the potential for ALI treatment, and the programmable DNA origami nanostructures provide a new drug delivery platform for pulmonary disease treatment with high delivery efficiency and biosecurity.
doi_str_mv 10.1021/acs.nanolett.4c01222
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3054839789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054839789</sourcerecordid><originalsourceid>FETCH-LOGICAL-a297t-cda33fc40acdd75effb580a0807875ba28ccbc2790399f0351ef9f95c29fabff3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EolD4A4SyZJMysWNiL6PyqlRaJMo6chy7uEriYidI5etx1ceSzcxIc-8dzUHoJoFRAji5F9KPWtHaWnXdKJWQYIxP0EVCCcQPnOPT48zSAbr0fgUAnFA4RwPCMsJpxi7Qx0yVfW1-VRVN2i9Ri87YNrI6elfrzlQqfrOV0SasH2d5NHdmKRoTLWyU17X6MaJTUS77UKd9uwwRq95trtCZFrVX1_s-RJ_PT4vxazydv0zG-TQWmGddLCtBiJYpCFlVGVVal5SBAAYZy2gpMJOylDjjQDjXQGiiNNecSsy1KLUmQ3S3y107-90r3xWN8VLVtWiV7X1BgKaM8IzxIE13Uums907pYu1MI9ymSKDY4iwCzuKAs9jjDLbb_YW-bFR1NB34BQHsBFv7yvauDQ__n_kHXNeFUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054839789</pqid></control><display><type>article</type><title>Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury</title><source>ACS Publications</source><source>MEDLINE</source><creator>Wang, Haiyan ; Jiao, Yunfei ; Ma, Shuaijing ; Li, Zhuoting ; Gong, Jintao ; Jiang, Qiao ; Shang, Yingxu ; Li, Hongling ; Li, Jing ; Li, Na ; Zhao, Robert Chunhua ; Ding, Baoquan</creator><creatorcontrib>Wang, Haiyan ; Jiao, Yunfei ; Ma, Shuaijing ; Li, Zhuoting ; Gong, Jintao ; Jiang, Qiao ; Shang, Yingxu ; Li, Hongling ; Li, Jing ; Li, Na ; Zhao, Robert Chunhua ; Ding, Baoquan</creatorcontrib><description>Acute lung injury (ALI) is a severe inflammatory lung disease, with high mortality rates. Early intervention by reactive oxygen species (ROS) scavengers could reduce ROS accumulation, break the inflammation expansion chain in alveolar macrophages (AMs), and avoid irreversible damage to alveolar epithelial and endothelial cells. Here, we reported cell-penetrating R9 peptide-modified triangular DNA origami nanostructures (tDONs-R9) as a novel nebulizable drug that could reach the deep alveolar regions and exhibit an enhanced uptake preference of macrophages. tDONs-R9 suppressed the expression of pro-inflammatory cytokines and drove polarization toward the anti-inflammatory M2 phenotype in macrophages. In the LPS-induced ALI mouse model, treatment with nebulized tDONs-R9 alleviated the overwhelming ROS, pro-inflammatory cytokines, and neutrophil infiltration in the lungs. Our study demonstrates that tDONs-R9 has the potential for ALI treatment, and the programmable DNA origami nanostructures provide a new drug delivery platform for pulmonary disease treatment with high delivery efficiency and biosecurity.</description><identifier>ISSN: 1530-6984</identifier><identifier>EISSN: 1530-6992</identifier><identifier>DOI: 10.1021/acs.nanolett.4c01222</identifier><identifier>PMID: 38739578</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acute Lung Injury - chemically induced ; Acute Lung Injury - drug therapy ; Acute Lung Injury - pathology ; Administration, Inhalation ; Animals ; Cell-Penetrating Peptides - chemistry ; Cytokines - metabolism ; Disease Models, Animal ; DNA - chemistry ; Drug Delivery Systems ; Lipopolysaccharides ; Macrophages, Alveolar - drug effects ; Macrophages, Alveolar - metabolism ; Mice ; Nanostructures - chemistry ; Nebulizers and Vaporizers ; Peptides - chemistry ; RAW 264.7 Cells ; Reactive Oxygen Species - metabolism</subject><ispartof>Nano letters, 2024-05, Vol.24 (20), p.6102-6111</ispartof><rights>2024 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a297t-cda33fc40acdd75effb580a0807875ba28ccbc2790399f0351ef9f95c29fabff3</cites><orcidid>0000-0003-1095-8872 ; 0000-0002-2587-6944</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.4c01222$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.nanolett.4c01222$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38739578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Haiyan</creatorcontrib><creatorcontrib>Jiao, Yunfei</creatorcontrib><creatorcontrib>Ma, Shuaijing</creatorcontrib><creatorcontrib>Li, Zhuoting</creatorcontrib><creatorcontrib>Gong, Jintao</creatorcontrib><creatorcontrib>Jiang, Qiao</creatorcontrib><creatorcontrib>Shang, Yingxu</creatorcontrib><creatorcontrib>Li, Hongling</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Na</creatorcontrib><creatorcontrib>Zhao, Robert Chunhua</creatorcontrib><creatorcontrib>Ding, Baoquan</creatorcontrib><title>Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury</title><title>Nano letters</title><addtitle>Nano Lett</addtitle><description>Acute lung injury (ALI) is a severe inflammatory lung disease, with high mortality rates. Early intervention by reactive oxygen species (ROS) scavengers could reduce ROS accumulation, break the inflammation expansion chain in alveolar macrophages (AMs), and avoid irreversible damage to alveolar epithelial and endothelial cells. Here, we reported cell-penetrating R9 peptide-modified triangular DNA origami nanostructures (tDONs-R9) as a novel nebulizable drug that could reach the deep alveolar regions and exhibit an enhanced uptake preference of macrophages. tDONs-R9 suppressed the expression of pro-inflammatory cytokines and drove polarization toward the anti-inflammatory M2 phenotype in macrophages. In the LPS-induced ALI mouse model, treatment with nebulized tDONs-R9 alleviated the overwhelming ROS, pro-inflammatory cytokines, and neutrophil infiltration in the lungs. Our study demonstrates that tDONs-R9 has the potential for ALI treatment, and the programmable DNA origami nanostructures provide a new drug delivery platform for pulmonary disease treatment with high delivery efficiency and biosecurity.</description><subject>Acute Lung Injury - chemically induced</subject><subject>Acute Lung Injury - drug therapy</subject><subject>Acute Lung Injury - pathology</subject><subject>Administration, Inhalation</subject><subject>Animals</subject><subject>Cell-Penetrating Peptides - chemistry</subject><subject>Cytokines - metabolism</subject><subject>Disease Models, Animal</subject><subject>DNA - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Lipopolysaccharides</subject><subject>Macrophages, Alveolar - drug effects</subject><subject>Macrophages, Alveolar - metabolism</subject><subject>Mice</subject><subject>Nanostructures - chemistry</subject><subject>Nebulizers and Vaporizers</subject><subject>Peptides - chemistry</subject><subject>RAW 264.7 Cells</subject><subject>Reactive Oxygen Species - metabolism</subject><issn>1530-6984</issn><issn>1530-6992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EolD4A4SyZJMysWNiL6PyqlRaJMo6chy7uEriYidI5etx1ceSzcxIc-8dzUHoJoFRAji5F9KPWtHaWnXdKJWQYIxP0EVCCcQPnOPT48zSAbr0fgUAnFA4RwPCMsJpxi7Qx0yVfW1-VRVN2i9Ri87YNrI6elfrzlQqfrOV0SasH2d5NHdmKRoTLWyU17X6MaJTUS77UKd9uwwRq95trtCZFrVX1_s-RJ_PT4vxazydv0zG-TQWmGddLCtBiJYpCFlVGVVal5SBAAYZy2gpMJOylDjjQDjXQGiiNNecSsy1KLUmQ3S3y107-90r3xWN8VLVtWiV7X1BgKaM8IzxIE13Uums907pYu1MI9ymSKDY4iwCzuKAs9jjDLbb_YW-bFR1NB34BQHsBFv7yvauDQ__n_kHXNeFUA</recordid><startdate>20240522</startdate><enddate>20240522</enddate><creator>Wang, Haiyan</creator><creator>Jiao, Yunfei</creator><creator>Ma, Shuaijing</creator><creator>Li, Zhuoting</creator><creator>Gong, Jintao</creator><creator>Jiang, Qiao</creator><creator>Shang, Yingxu</creator><creator>Li, Hongling</creator><creator>Li, Jing</creator><creator>Li, Na</creator><creator>Zhao, Robert Chunhua</creator><creator>Ding, Baoquan</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1095-8872</orcidid><orcidid>https://orcid.org/0000-0002-2587-6944</orcidid></search><sort><creationdate>20240522</creationdate><title>Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury</title><author>Wang, Haiyan ; Jiao, Yunfei ; Ma, Shuaijing ; Li, Zhuoting ; Gong, Jintao ; Jiang, Qiao ; Shang, Yingxu ; Li, Hongling ; Li, Jing ; Li, Na ; Zhao, Robert Chunhua ; Ding, Baoquan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a297t-cda33fc40acdd75effb580a0807875ba28ccbc2790399f0351ef9f95c29fabff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute Lung Injury - chemically induced</topic><topic>Acute Lung Injury - drug therapy</topic><topic>Acute Lung Injury - pathology</topic><topic>Administration, Inhalation</topic><topic>Animals</topic><topic>Cell-Penetrating Peptides - chemistry</topic><topic>Cytokines - metabolism</topic><topic>Disease Models, Animal</topic><topic>DNA - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Lipopolysaccharides</topic><topic>Macrophages, Alveolar - drug effects</topic><topic>Macrophages, Alveolar - metabolism</topic><topic>Mice</topic><topic>Nanostructures - chemistry</topic><topic>Nebulizers and Vaporizers</topic><topic>Peptides - chemistry</topic><topic>RAW 264.7 Cells</topic><topic>Reactive Oxygen Species - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Haiyan</creatorcontrib><creatorcontrib>Jiao, Yunfei</creatorcontrib><creatorcontrib>Ma, Shuaijing</creatorcontrib><creatorcontrib>Li, Zhuoting</creatorcontrib><creatorcontrib>Gong, Jintao</creatorcontrib><creatorcontrib>Jiang, Qiao</creatorcontrib><creatorcontrib>Shang, Yingxu</creatorcontrib><creatorcontrib>Li, Hongling</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Na</creatorcontrib><creatorcontrib>Zhao, Robert Chunhua</creatorcontrib><creatorcontrib>Ding, Baoquan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nano letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Haiyan</au><au>Jiao, Yunfei</au><au>Ma, Shuaijing</au><au>Li, Zhuoting</au><au>Gong, Jintao</au><au>Jiang, Qiao</au><au>Shang, Yingxu</au><au>Li, Hongling</au><au>Li, Jing</au><au>Li, Na</au><au>Zhao, Robert Chunhua</au><au>Ding, Baoquan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury</atitle><jtitle>Nano letters</jtitle><addtitle>Nano Lett</addtitle><date>2024-05-22</date><risdate>2024</risdate><volume>24</volume><issue>20</issue><spage>6102</spage><epage>6111</epage><pages>6102-6111</pages><issn>1530-6984</issn><eissn>1530-6992</eissn><abstract>Acute lung injury (ALI) is a severe inflammatory lung disease, with high mortality rates. Early intervention by reactive oxygen species (ROS) scavengers could reduce ROS accumulation, break the inflammation expansion chain in alveolar macrophages (AMs), and avoid irreversible damage to alveolar epithelial and endothelial cells. Here, we reported cell-penetrating R9 peptide-modified triangular DNA origami nanostructures (tDONs-R9) as a novel nebulizable drug that could reach the deep alveolar regions and exhibit an enhanced uptake preference of macrophages. tDONs-R9 suppressed the expression of pro-inflammatory cytokines and drove polarization toward the anti-inflammatory M2 phenotype in macrophages. In the LPS-induced ALI mouse model, treatment with nebulized tDONs-R9 alleviated the overwhelming ROS, pro-inflammatory cytokines, and neutrophil infiltration in the lungs. Our study demonstrates that tDONs-R9 has the potential for ALI treatment, and the programmable DNA origami nanostructures provide a new drug delivery platform for pulmonary disease treatment with high delivery efficiency and biosecurity.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>38739578</pmid><doi>10.1021/acs.nanolett.4c01222</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-1095-8872</orcidid><orcidid>https://orcid.org/0000-0002-2587-6944</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1530-6984
ispartof Nano letters, 2024-05, Vol.24 (20), p.6102-6111
issn 1530-6984
1530-6992
language eng
recordid cdi_proquest_miscellaneous_3054839789
source ACS Publications; MEDLINE
subjects Acute Lung Injury - chemically induced
Acute Lung Injury - drug therapy
Acute Lung Injury - pathology
Administration, Inhalation
Animals
Cell-Penetrating Peptides - chemistry
Cytokines - metabolism
Disease Models, Animal
DNA - chemistry
Drug Delivery Systems
Lipopolysaccharides
Macrophages, Alveolar - drug effects
Macrophages, Alveolar - metabolism
Mice
Nanostructures - chemistry
Nebulizers and Vaporizers
Peptides - chemistry
RAW 264.7 Cells
Reactive Oxygen Species - metabolism
title Nebulized Inhalation of Peptide-Modified DNA Origami To Alleviate Acute Lung Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A25%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nebulized%20Inhalation%20of%20Peptide-Modified%20DNA%20Origami%20To%20Alleviate%20Acute%20Lung%20Injury&rft.jtitle=Nano%20letters&rft.au=Wang,%20Haiyan&rft.date=2024-05-22&rft.volume=24&rft.issue=20&rft.spage=6102&rft.epage=6111&rft.pages=6102-6111&rft.issn=1530-6984&rft.eissn=1530-6992&rft_id=info:doi/10.1021/acs.nanolett.4c01222&rft_dat=%3Cproquest_cross%3E3054839789%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054839789&rft_id=info:pmid/38739578&rfr_iscdi=true